| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 77,398,000 | 59.45% | ||
| 2 | Catabasis Pharmaceuticals Inc | 2,857,667 | 17,602,000 | 13.52% | ||
| 3 | OCULAR THERAPEUTIX INC | 1,932,607 | 13,277,000 | 10.20% | ||
| 4 | TRANSENTERIX INC | 7,546,692 | 12,754,000 | 9.80% | ||
| 5 | RAPTOR PHARMACEUTICAL CORP | 888,132 | 7,966,000 | 6.12% | ||
| 6 | LOMBARD MEDICAL INC | 1,275,779 | 1,199,000 | 0.92% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-022022, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
